TP53 and breast cancer: Targeted Anticancer Mechanism of DHIE: Our study uncovers a novel mechanism by which Dehydrodiisoeugenol (DHIE) inhibits cancer cell proliferation by blocking the breast cancer cell cycle through the PLK1-p53 signaling axis.